By: Dr. Karin Hehenberger
Lyfebulb only launched a few months ago, but it had been a dream of mine for many years prior. I have always wanted to make an impact, to go against the norm and embrace innovation and new ideas to find solutions to difficult problems. Growing up, I enjoyed learning and being active more than anything. I excelled both in sports and in school. But above all, I was notoriously gleeful, — very few things seemed to make me sad. I had the unconditional love and support from my family. I believe that all of this helped me later in life, but a few things have changed dramatically – one being my confidence in myself and the other, my belief in happy endings.
I am still an optimistic person, in fact, some people would even argue I am too enthusiastic at times. I tend to see the glass half-full and to perceive obstacles as opportunities rather than hurdles. I thrive on socializing and working with interesting characters. Very few things make me happier, or give me more energy, than being surrounded by smart and dedicated people. I love debates and I encourage questions. It stimulates my mind and gives me a reason to go on. When I was diagnosed with Type 1 Diabetes in 1989 as a 16 year old with no previous “defects” or real defeats, I lost my belief in God and my belief to a certain extent in my parents’ ability to fix everything. I had already realized that my parents were not invincible (I beat them both in tennis, running, etc.), but I still thought they could keep me healthy and happy. Though Diabetes took that away from me; it gave me another reason to fight – not only to show to the world I was stronger and smarter, but also that I was a survivor.
This is what “invest in your own disease” is about. There is no one out there who can innovate, develop, fight, engage, analyze, or finance better than the ones who struggle with the actual condition every single day. I live this principle each day, and have throughout my career as a medical scientist, specializing in diabetes, and then working in the biopharmaceutical industry as both an investor as well as an executive, financing and developing product for people with diabetes and other diseases.
Lyfebulb aims to create a community for these people, to allow for them to engage in our four different divisions:
1: Lyfebulb Social Club for informal gatherings at great restaurants, where people can learn about a new technology or from each other, over small bites and cocktails.
2: Lyfebulb Impact for early-stage investments into companies or entrepreneurs that potentially could make a practical difference to people living with Diabetes, Celiac or Crohn’s/Colitis.
3: Lyfebulb Boutique for access to consumer products simplifying and improving daily life from a health and wellness perspective.
4: Lyfebulb Digital for online access through our social media, website and blog.